4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000003
CFO AND TREASURER sold 10,000 shares at an average $527.48 ($5,274,802)
- CFO AND TREASURER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
18 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $135.42 | $1,354,200 | 28,876 | D |
| 2026-03-23 | Sale : show line 2 in the form 10b5-1 | −200 | $518.28 | $103,657 | 28,676 | D |
| 2026-03-23 | Sale : show line 3 in the form 10b5-1 | −640 | $519.30 | $332,354 | 28,036 | D |
| 2026-03-23 | Sale : show line 4 in the form 10b5-1 | −875 | $520.62 | $455,539 | 27,161 | D |
| 2026-03-23 | Sale : show line 5 in the form 10b5-1 | −905 | $521.47 | $471,927 | 26,256 | D |
| 2026-03-23 | Sale : show line 6 in the form 10b5-1 | −200 | $522.36 | $104,473 | 26,056 | D |
| 2026-03-23 | Sale : show line 7 in the form 10b5-1 | −440 | $524.20 | $230,648 | 25,616 | D |
| 2026-03-23 | Sale : show line 8 in the form 10b5-1 | −320 | $525.37 | $168,118 | 25,296 | D |
| Open-market sales · 10,000 sh · avg $527.48 · $5,274,802 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-23 | Exercise or conversion : show line 19 in the form 10b5-1 Stock Option | −10,000 | 152,500 | D |
Loading xslF345X06/primarydocument.xml…